AXQ Capital’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,960
Closed -$1.66M 1147
2026
Q1
$1.66M Buy
+2,960
New +$1.9M 0.21% 151
2024
Q4
Sell
-1,662
Closed -$840K 529
2024
Q3
$840K Buy
1,662
+396
+31% +$192K 0.25% 154
2024
Q2
$617K Buy
+1,266
New +$636K 0.14% 256
2023
Q1
Sell
-1,044
Closed -$426K 552
2022
Q4
$426K Buy
+1,044
New +$405K 0.3% 124

Other funds holding IDXX

AXQ Capital's IDXX Position: Q2 2026 in Review

AXQ Capital sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 2,960 shares — an estimated $1.66M sold.

AXQ Capital first reported a position in IDXX in Q4 2022 and held it in 4 quarters. The position peaked at $1.66M in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • AXQ Capital reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • AXQ Capital sold 2,960 Idexx Laboratories shares in Q2 2026, an estimated $1.66M.
  • AXQ Capital first reported a position in Idexx Laboratories in Q4 2022 and held it in 4 quarters.
  • AXQ Capital's Idexx Laboratories position peaked at $1.66M in Q1 2026.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.